Skip to main content
PMC home page
Annals of Surgery logoLink to Annals of Surgery
. 1998 Jan;227(1):80–85. doi: 10.1097/00000658-199801000-00012

Prognostic factors after repeat hepatectomy for recurrent hepatocellular carcinoma.

M Shimada 1, K Takenaka 1, K Taguchi 1, Y Fujiwara 1, T Gion 1, K Kajiyama 1, T Maeda 1, K Shirabe 1, K Yanaga 1, K Sugimachi 1
PMCID: PMC1191176  PMID: 9445114

Abstract

OBJECTIVE: The aims of this study were to identify prognostic factors in patients who developed recurrent hepatocellular carcinoma (HCC) after repeat hepatectomy and to elucidate the role of multicentric occurrence in the second tumor after a first hepatectomy. SUMMARY BACKGROUND DATA: A repeat hepatectomy for recurrent HCC has been established as the most effective treatment modality, whenever it is possible. However, the prognostic factors for recurrent HCC after repeat hepatectomy have yet to be clarified. METHODS: Forty-one patients who underwent a curative repeat hepatectomy were retrospectively studied. Patient survival and disease-free survival after recurrence were univariately and multivariately analyzed using 38 clinicopathologic variables. The histologic grade of HCC at repeat hepatectomy was also compared with that at first hepatectomy. RESULTS: Patient survival after repeat hepatectomy did not differ substantially from that in 312 patients undergoing primary hepatectomy. However, the disease-free survival after repeat hepatectomy was significantly lower than that in patients with only a primary hepatectomy (p < 0.05). Multivariate analysis revealed only portal vein invasion in the first hepatectomy to be an independent and significantly poor prognostic factor. Regarding multicentric occurrence at repeat hepatectomy, only 6 of 40 patients (15%) whose specimens could be evaluated histologically were determined to be Edmondson and Steiner's Grade 1. CONCLUSIONS: The only prognostic factor identified in patients with recurrent HCC after repeat hepatectomy was portal vein invasion in the first hepatectomy. Most second tumors after the first hepatectomy are considered to be caused by metastatic recurrence, not by multicentric occurrence.

Full text

PDF
85

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chen M. F., Hwang T. L., Jeng L. B., Wang C. S., Jan Y. Y., Chen S. C. Postoperative recurrence of hepatocellular carcinoma. Two hundred five consecutive patients who underwent hepatic resection in 15 years. Arch Surg. 1994 Jul;129(7):738–742. doi: 10.1001/archsurg.1994.01420310070012. [DOI] [PubMed] [Google Scholar]
  2. EDMONDSON H. A., STEINER P. E. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer. 1954 May;7(3):462–503. doi: 10.1002/1097-0142(195405)7:3<462::aid-cncr2820070308>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  3. Hsu H. C., Chiou T. J., Chen J. Y., Lee C. S., Lee P. H., Peng S. Y. Clonality and clonal evolution of hepatocellular carcinoma with multiple nodules. Hepatology. 1991 May;13(5):923–928. [PubMed] [Google Scholar]
  4. Huguet C., Bona S., Nordlinger B., Lagrange L., Parc R., Harb J., Benard F. Repeat hepatic resection for primary and metastatic carcinoma of the liver. Surg Gynecol Obstet. 1990 Nov;171(5):398–402. [PubMed] [Google Scholar]
  5. Izumi R., Shimizu K., Ii T., Yagi M., Matsui O., Nonomura A., Miyazaki I. Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection. Gastroenterology. 1994 Mar;106(3):720–727. doi: 10.1016/0016-5085(94)90707-2. [DOI] [PubMed] [Google Scholar]
  6. Kanai T., Hirohashi S., Upton M. P., Noguchi M., Kishi K., Makuuchi M., Yamasaki S., Hasegawa H., Takayasu K., Moriyama N. Pathology of small hepatocellular carcinoma. A proposal for a new gross classification. Cancer. 1987 Aug 15;60(4):810–819. doi: 10.1002/1097-0142(19870815)60:4<810::aid-cncr2820600417>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  7. Kanematsu T., Furuta T., Takenaka K., Matsumata T., Yoshida Y., Nishizaki T., Hasuo K., Sugimachi K. A 5-year experience of lipiodolization: selective regional chemotherapy for 200 patients with hepatocellular carcinoma. Hepatology. 1989 Jul;10(1):98–102. doi: 10.1002/hep.1840100119. [DOI] [PubMed] [Google Scholar]
  8. Kondo Y., Wada K. Intrahepatic metastasis of hepatocellular carcinoma: a histopathologic study. Hum Pathol. 1991 Feb;22(2):125–130. doi: 10.1016/0046-8177(91)90033-l. [DOI] [PubMed] [Google Scholar]
  9. Liebman H. A., Furie B. C., Tong M. J., Blanchard R. A., Lo K. J., Lee S. D., Coleman M. S., Furie B. Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. N Engl J Med. 1984 May 31;310(22):1427–1431. doi: 10.1056/NEJM198405313102204. [DOI] [PubMed] [Google Scholar]
  10. Matsuda Y., Ito T., Oguchi Y., Nakajima K., Izukura T. Rationale of surgical management for recurrent hepatocellular carcinoma. Ann Surg. 1993 Jan;217(1):28–34. doi: 10.1097/00000658-199301000-00006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Matsumata T., Kanematsu T., Takenaka K., Yoshida Y., Nishizaki T., Sugimachi K. Patterns of intrahepatic recurrence after curative resection of hepatocellular carcinoma. Hepatology. 1989 Mar;9(3):457–460. doi: 10.1002/hep.1840090320. [DOI] [PubMed] [Google Scholar]
  12. Nagasue N., Kohno H., Hayashi T., Uchida M., Ono T., Yukaya H., Yamanoi A. Repeat hepatectomy for recurrent hepatocellular carcinoma. Br J Surg. 1996 Jan;83(1):127–131. doi: 10.1002/bjs.1800830142. [DOI] [PubMed] [Google Scholar]
  13. Nagasue N., Uchida M., Makino Y., Takemoto Y., Yamanoi A., Hayashi T., Chang Y. C., Kohno H., Nakamura T., Yukaya H. Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology. 1993 Aug;105(2):488–494. doi: 10.1016/0016-5085(93)90724-q. [DOI] [PubMed] [Google Scholar]
  14. Okada S., Shimada K., Yamamoto J., Takayama T., Kosuge T., Yamasaki S., Sakamoto M., Hirohashi S. Predictive factors for postoperative recurrence of hepatocellular carcinoma. Gastroenterology. 1994 Jun;106(6):1618–1624. doi: 10.1016/0016-5085(94)90419-7. [DOI] [PubMed] [Google Scholar]
  15. Ouchi K., Matsubara S., Fukuhara K., Tominaga T., Matsuno S. Recurrence of hepatocellular carcinoma in the liver remnant after hepatic resection. Am J Surg. 1993 Sep;166(3):270–273. doi: 10.1016/s0002-9610(05)80972-9. [DOI] [PubMed] [Google Scholar]
  16. Peto R., Pike M. C. Conservatism of the approximation sigma (O-E)2-E in the logrank test for survival data or tumor incidence data. Biometrics. 1973 Sep;29(3):579–584. [PubMed] [Google Scholar]
  17. Sakamoto M., Hirohashi S., Shimosato Y. Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma. Hum Pathol. 1991 Feb;22(2):172–178. doi: 10.1016/0046-8177(91)90039-r. [DOI] [PubMed] [Google Scholar]
  18. Sakamoto M., Hirohashi S., Tsuda H., Shimosato Y., Makuuchi M., Hosoda Y. Multicentric independent development of hepatocellular carcinoma revealed by analysis of hepatitis B virus integration pattern. Am J Surg Pathol. 1989 Dec;13(12):1064–1067. doi: 10.1097/00000478-198912000-00009. [DOI] [PubMed] [Google Scholar]
  19. Shimada M., Matsumata T., Taketomi A., Yamamoto K., Itasaka H., Sugimachi K. Repeat hepatectomy for recurrent hepatocellular carcinoma. Surgery. 1994 Jun;115(6):703–706. [PubMed] [Google Scholar]
  20. Shimada M., Takenaka K., Gion T., Fujiwara Y., Kajiyama K., Maeda T., Shirabe K., Nishizaki T., Yanaga K., Sugimachi K. Prognosis of recurrent hepatocellular carcinoma: a 10-year surgical experience in Japan. Gastroenterology. 1996 Sep;111(3):720–726. doi: 10.1053/gast.1996.v111.pm8780578. [DOI] [PubMed] [Google Scholar]
  21. Shirabe K., Kanematsu T., Matsumata T., Adachi E., Akazawa K., Sugimachi K. Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: univariate and multivariate analyses. Hepatology. 1991 Nov;14(5):802–805. doi: 10.1002/hep.1840140510. [DOI] [PubMed] [Google Scholar]
  22. Shirabe K., Takenaka K., Taketomi A., Kawahara N., Yamamoto K., Shimada M., Sugimachi K. Postoperative hepatitis status as a significant risk factor for recurrence in cirrhotic patients with small hepatocellular carcinoma. Cancer. 1996 Mar 15;77(6):1050–1055. [PubMed] [Google Scholar]
  23. Suenaga M., Sugiura H., Kokuba Y., Uehara S., Kurumiya T. Repeated hepatic resection for recurrent hepatocellular carcinoma in eighteen cases. Surgery. 1994 Apr;115(4):452–457. [PubMed] [Google Scholar]
  24. Takenaka K., Adachi E., Nishizaki T., Hiroshige K., Ikeda T., Tsuneyoshi M., Sugimachi K. Possible multicentric occurrence of hepatocellular carcinoma: a clinicopathological study. Hepatology. 1994 Apr;19(4):889–894. [PubMed] [Google Scholar]
  25. Takenaka K., Yoshida K., Nishizaki T., Korenaga D., Hiroshige K., Ikeda T., Sugimachi K. Postoperative prophylactic lipiodolization reduces the intrahepatic recurrence of hepatocellular carcinoma. Am J Surg. 1995 Apr;169(4):400–405. doi: 10.1016/s0002-9610(99)80184-6. [DOI] [PubMed] [Google Scholar]
  26. Tsuda H., Hirohashi S., Shimosato Y., Terada M., Hasegawa H. Clonal origin of atypical adenomatous hyperplasia of the liver and clonal identity with hepatocellular carcinoma. Gastroenterology. 1988 Dec;95(6):1664–1666. doi: 10.1016/s0016-5085(88)80093-3. [DOI] [PubMed] [Google Scholar]
  27. Tsuda H., Oda T., Sakamoto M., Hirohashi S. Different pattern of chromosomal allele loss in multiple hepatocellular carcinomas as evidence of their multifocal origin. Cancer Res. 1992 Mar 15;52(6):1504–1509. [PubMed] [Google Scholar]
  28. Urata K., Matsumata T., Kamakura T., Hasuo K., Sugimachi K. Lipiodolization for unresectable hepatocellular carcinoma: an analysis of 205 patients using univariate and multivariate analysis. J Surg Oncol. 1994 May;56(1):54–58. doi: 10.1002/jso.2930560113. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES